Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

571 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase 2 clinical trial of luspatercept in non-transfusion-dependent patients with myelodysplastic syndromes.
Kosugi H, Fujisaki T, Iwasaki H, Shinagawa A, Iida H, Jo T, Kubonishi S, Morita Y, Nakashima Y, Onodera K, Suzuki K, Suzuki T, Tamai Y, Usuki K, Yokota A, Yonaga H, Hayakawa J, Midorikawa S, Nishio M, Suda M, Matsue K. Kosugi H, et al. Among authors: suda m. Int J Hematol. 2024 Nov 21. doi: 10.1007/s12185-024-03872-3. Online ahead of print. Int J Hematol. 2024. PMID: 39572468
Tocilizumab for Giant Cell Arteritis: Clinical Outcomes Following Relapses and Tocilizumab Discontinuation Due to Adverse Events.
Nagase FN, Fukui S, Takizawa N, Yamaguchi T, Oda N, Inokuchi H, Ito T, Watanabe M, Suda M, Haji Y, Suyama Y, Rokutanda R, Minoda M, Nomura A, Uechi E, Tamaki H. Nagase FN, et al. Among authors: suda m. J Rheumatol. 2024 Nov 15:jrheum.2024-0612. doi: 10.3899/jrheum.2024-0612. Online ahead of print. J Rheumatol. 2024. PMID: 39547687
Booster vaccination using bivalent DS-5670a/b is safe and immunogenic against SARS-CoV-2 variants in children aged 5-11 years: a phase 2/3, randomized, active-controlled study.
Suzuki R, Suda M, Ishida K, Furihata K, Ota A, Takahashi K, Sakakibara S, Nakayama T, Takeshita F. Suzuki R, et al. Among authors: suda m. Front Immunol. 2024 Sep 2;15:1445459. doi: 10.3389/fimmu.2024.1445459. eCollection 2024. Front Immunol. 2024. PMID: 39286253 Free PMC article. Clinical Trial.
SGLT2 inhibition eliminates senescent cells and alleviates pathological aging.
Katsuumi G, Shimizu I, Suda M, Yoshida Y, Furihata T, Joki Y, Hsiao CL, Jiaqi L, Fujiki S, Abe M, Sugimoto M, Soga T, Minamino T. Katsuumi G, et al. Among authors: suda m. Nat Aging. 2024 Jul;4(7):926-938. doi: 10.1038/s43587-024-00642-y. Epub 2024 May 30. Nat Aging. 2024. PMID: 38816549 Free PMC article.
Profiling microRNA expression during senescence and aging: mining for a diagnostic tool of senescent-cell burden.
Weigl M, Krammer TL, Pultar M, Wieser M, Chaib S, Suda M, Diendorfer A, Khamina-Kotisch K, Giorgadze N, Pirtskhalava T, Johnson KO, Inman CL, Xue A, Lämmermann I, Meixner B, Wang L, Xu M, Grillari R, Ogrodnik M, Tchkonia T, Hackl M, Kirkland JL, Grillari J. Weigl M, et al. Among authors: suda m. bioRxiv [Preprint]. 2024 Apr 10:2024.04.10.588794. doi: 10.1101/2024.04.10.588794. bioRxiv. 2024. PMID: 38645053 Free PMC article. Preprint.
571 results